Health
Obesity Drugs Show Promise Against Hormonal Disorder PMOS
GLP-1 obesity drugs show early promise treating PMOS, a hormonal disorder affecting 170 million women, but insurance barriers remain.
—4 min read
Tag
#Glp 1
5 articles
Health
Jillian Michaels Warns of Gray Market Weight Loss Drug Risks
Jillian Michaels warns against self-dosing unregulated 'gray market' weight loss peptides amid FDA crackdown.
—4 min read
HealthMedicine
The Black Market for Retatrutide, the Super-Ozempic
Demand for Eli Lilly's unapproved weight-loss drug retatrutide has spawned a thriving black market. At least 14 hospitalizations linked to its use.
—4 min read
HealthScience
GLP-1 Drugs May Protect Against Cancer, Studies Suggest
New research at ASCO 2026 suggests GLP-1 drugs like Ozempic and Wegovy may reduce cancer risk and slow progression beyond weight loss.
—5 min read
Health & Science
Eli Lilly's Retatrutide Yields 28% Weight Loss in Trial
Eli Lilly's retatrutide led to 28.3% weight loss in a Phase 3 trial, approaching bariatric surgery results. But high side effect rates raise questions.
—5 min read